| Dr Aisha Khan, MD | |
|
111 Wakelee Ave, Ansonia, CT 06401 | |
| (203) 308-2781 | |
| Not Available |
| Full Name | Dr Aisha Khan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 111 Wakelee Ave, Ansonia, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265939540 | NPI | - | NPPES |
| 000000 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 69021 (Connecticut) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Griffin Hospital | Derby, CT | Hospital |
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Griffin Faculty Physicians Inc | 7618871997 | 107 |
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
News Archive
The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. "Vaccines are no longer a sleepy, low-profit niche in a booming drug industry.
Because the Met Office in London are predicting that average British temperatures in July and August this year could be unusually high, with potentially devastating consequences, the British Government has acted to combat a disaster that they feel could threaten thousands of lives - a hot summer.
Vital Therapies, Inc., (VTI) is pleased to announce that the first two subjects have been enrolled at King's College Hospital in London in the expansion of its SILVER (Stabilization In LiVER failure) clinical trial in Europe. The trial is evaluating whether VTI's biological cellular therapy product, ELAD®, can prevent deterioration of liver function and improve the survival of patients with acute-on-chronic liver failure (ACLF).
MicroStockProfit.com announces an investment report featuring Imaging3 Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
› Verified 6 days ago
| Entity Name | Griffin Faculty Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. "Vaccines are no longer a sleepy, low-profit niche in a booming drug industry.
Because the Met Office in London are predicting that average British temperatures in July and August this year could be unusually high, with potentially devastating consequences, the British Government has acted to combat a disaster that they feel could threaten thousands of lives - a hot summer.
Vital Therapies, Inc., (VTI) is pleased to announce that the first two subjects have been enrolled at King's College Hospital in London in the expansion of its SILVER (Stabilization In LiVER failure) clinical trial in Europe. The trial is evaluating whether VTI's biological cellular therapy product, ELAD®, can prevent deterioration of liver function and improve the survival of patients with acute-on-chronic liver failure (ACLF).
MicroStockProfit.com announces an investment report featuring Imaging3 Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aisha Khan, MD 67 Maple Ave, Derby, CT 06418-1328 Ph: (203) 732-1256 | Dr Aisha Khan, MD 111 Wakelee Ave, Ansonia, CT 06401 Ph: (203) 308-2781 |
News Archive
The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. "Vaccines are no longer a sleepy, low-profit niche in a booming drug industry.
Because the Met Office in London are predicting that average British temperatures in July and August this year could be unusually high, with potentially devastating consequences, the British Government has acted to combat a disaster that they feel could threaten thousands of lives - a hot summer.
Vital Therapies, Inc., (VTI) is pleased to announce that the first two subjects have been enrolled at King's College Hospital in London in the expansion of its SILVER (Stabilization In LiVER failure) clinical trial in Europe. The trial is evaluating whether VTI's biological cellular therapy product, ELAD®, can prevent deterioration of liver function and improve the survival of patients with acute-on-chronic liver failure (ACLF).
MicroStockProfit.com announces an investment report featuring Imaging3 Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
› Verified 6 days ago
Dr. Stephen J. Moses, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 135 Division St, Ansonia, CT 06401 Phone: 203-735-9354 Fax: 203-732-2106 | |
Dr. Chi Tang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 135 Division St Ste 1, Ansonia, CT 06401 Phone: 203-735-3500 Fax: 203-735-0505 | |
Bruce T Brennan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Westfield Ave, Ansonia, CT 06401 Phone: 203-734-7100 Fax: 203-734-3392 | |
Sangeetha Rajan, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 111 Wakelee Ave, Ansonia, CT 06401 Phone: 203-308-2781 | |
Mr. Jonathan T Simon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Westfield Ave, Ansonia, CT 06401 Phone: 203-736-9919 Fax: 203-735-2055 | |
Dr. Joel S Zaretzky, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 199 Wakelee Ave, Ansonia, CT 06401 Phone: 203-735-5444 Fax: 203-735-1469 |